QJM. 2019 Mar 1;112(3):197-205. doi: 10.1093/qjmed/hcy277.
Acute Kidney Injury (AKI) is associated with adverse outcomes; therefore identifying patients who are at risk of developing AKI in hospital may lead to targeted prevention.
We undertook a UK-wide study in acute medical units (AMUs) to define those who develop hospital-acquired AKI (hAKI); to determine risk factors associated with hAKI and to assess the feasibility of developing a risk prediction score.
Prospective multi-centre cohort study across 72 AMUs in the UK.
Data collected from all patients who presented over a 24-h period. Chronic dialysis, community-acquired AKI (cAKI) and those with fewer than two creatinine measurements were excluded. Primary outcome was the development of h-AKI.
Two thousand four hundred and fourty-six individuals were admitted to the seventy-two participating centres. Three hundred and eighty-four patients (16%) sustained AKI of whom two hundred and eighty-seven (75%) were cAKI and ninety-seven (25%) were hAKI. After exclusions, chronic kidney disease [Odds Ratio (OR) 3.08, 95% Confidence Interval (CI) 1.96-4.83], diuretic prescription (OR 2.33, 95% CI 1.5-3.65), a lower haemoglobin concentration and elevated serum bilirubin were independently associated with development of hAKI. Multi-variable model discrimination was only moderate (c-statistic 0.75).
AKI in AMUs is common and associated with worse outcomes, with the majority of cases community acquired. Only a small proportion of patients develop hAKI. Prognostic risk factor modelling demonstrated only moderate discrimination implying that widespread adoption of such an AKI clinical risk score across all AMU admissions is not currently justified. More targeted risk assessment or automated methods of calculating individual risk may be more appropriate alternatives.
急性肾损伤(AKI)与不良结局相关;因此,识别医院中发生 AKI 的风险患者可能有助于进行针对性预防。
我们在急性内科病房(AMU)进行了一项英国范围内的研究,以确定发生医院获得性 AKI(hAKI)的人群;确定与 hAKI 相关的危险因素,并评估开发风险预测评分的可行性。
在英国 72 个 AMU 进行的前瞻性多中心队列研究。
收集所有在 24 小时内就诊的患者的数据。排除慢性透析、社区获得性 AKI(cAKI)和肌酐测量值少于两次的患者。主要结局是发生 h-AKI。
2446 人被收入 72 个参与中心。384 名患者(16%)发生 AKI,其中 287 名(75%)为 cAKI,97 名(25%)为 hAKI。排除后,慢性肾脏病[比值比(OR)3.08,95%置信区间(CI)1.96-4.83]、利尿剂处方(OR 2.33,95% CI 1.5-3.65)、较低的血红蛋白浓度和升高的血清胆红素与 hAKI 的发生独立相关。多变量模型的区分度仅为中度(c 统计量 0.75)。
AMU 中的 AKI 很常见,与更差的结局相关,其中大多数为社区获得性。只有一小部分患者发生 hAKI。预后风险因素模型仅具有中度区分度,这意味着目前还不能在所有 AMU 入院患者中广泛采用这种 AKI 临床风险评分。更有针对性的风险评估或计算个体风险的自动化方法可能是更合适的替代方法。